In: Biology
Treatments for Melanoma have always been slightly variant from the "standard" cancer treatments. The following is true of Melanoma as a form of cancer:
A. |
None of the other choices are correct. |
|
B. |
In part because of Melanoma's poor response to standard therapies, Targeted Therapies have been designed to block the pathways associated with two of the most common mutations associated with Melanoma: BRAF and NRAS. |
|
C. |
P-53 is the most common mutation associated with Melanoma. |
|
D. |
The prognosis for an individual diagnosed with Malignant Melanoma is relatively good, with a median survival time of 15 years. |
|
E. |
Because there are so many mutations associated with Melanoma, there is now way to genotype tumor cells to identify mutations. Therefore, BRAF therapy is offered to all patients because it is the most common mutation associated with the cancer. |